Literature DB >> 25196932

Kaposi's sarcoma at the University Teaching Hospital, Lusaka, Zambia in the antiretroviral therapy era.

Owen Ngalamika1, Veenu Minhas, Charles Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25196932      PMCID： PMC4268381          DOI： 10.1002/ijc.29184

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  5 in total

Review 1.  Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Authors:  Thomas S Uldrick; Denise Whitby
Journal:  Cancer Lett       Date:  2011-03-04       Impact factor: 8.679

2.  Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon.

Authors:  Kristen Stolka; Paul Ndom; Jennifer Hemingway-Foday; Jeniffer Iriondo-Perez; Wendell Miley; Nazzarena Labo; Jennifer Stella; Mahamat Abassora; Godfrey Woelk; Robin Ryder; Denise Whitby; Jennifer S Smith
Journal:  Cancer Epidemiol       Date:  2014-03-13       Impact factor: 2.984

3.  Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China.

Authors:  Fangping He; Xing Wang; Bin He; Zongdi Feng; Xiaomei Lu; Yaoxin Zhang; Shujun Zhao; Renyong Lin; Yan Hui; Yongxing Bao; Zhaoxia Zhang; Hao Wen
Journal:  J Med Virol       Date:  2007-02       Impact factor: 2.327

4.  Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.

Authors:  Julia Bohlius; Fabio Valeri; Mhairi Maskew; Hans Prozesky; Daniela Garone; Mazvita Sengayi; Matthew P Fox; Mary-Ann Davies; Matthias Egger
Journal:  Int J Cancer       Date:  2014-05-02       Impact factor: 7.396

5.  Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia.

Authors:  W Klaskala; B P Brayfield; C Kankasa; G Bhat; J T West; C D Mitchell; Charles Wood
Journal:  J Med Virol       Date:  2005-01       Impact factor: 2.327
  5 in total
  12 in total

1.  Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.

Authors:  Salum J Lidenge; For Yue Tso; Owen Ngalamika; John R Ngowi; Yasaman Mortazavi; Eun Hee Kwon; Danielle M Shea; Veenu Minhas; Julius Mwaiselage; Charles Wood; John T West
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

2.  Antiretroviral Therapy for HIV-Associated Cutaneous Kaposi's Sarcoma: Clinical, HIV-Related, and Sociodemographic Predictors of Outcome.

Authors:  Owen Ngalamika; Sody Munsaka; Salum J Lidenge; John T West; Charles Wood
Journal:  AIDS Res Hum Retroviruses       Date:  2021-02-02       Impact factor: 2.205

Review 3.  Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus.

Authors:  Veenu Minhas; Charles Wood
Journal:  Viruses       Date:  2014-11-04       Impact factor: 5.048

Review 4.  Kaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV-8.

Authors:  Carolyn C Jackson; Mark A Dickson; Mahan Sadjadi; Antoine Gessain; Laurent Abel; Emmanuelle Jouanguy; Jean-Laurent Casanova
Journal:  Pediatr Blood Cancer       Date:  2015-10-15       Impact factor: 3.167

5.  Outcome markers of ART-treated HIV+ patients with early stage Kaposi's sarcoma.

Authors:  Owen Ngalamika; For Yue Tso; Salum Lidenge; Sody Munsaka; Danielle Shea; Charles Wood; John West
Journal:  PLoS One       Date:  2020-07-07       Impact factor: 3.240

Review 6.  Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes.

Authors:  Gail E Reid; Joseph P Lynch; Samuel Weigt; David Sayah; John A Belperio; Shellee A Grim; Nina M Clark
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

7.  Comparative transcriptome analysis of endemic and epidemic Kaposi's sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis.

Authors:  Salum J Lidenge; Andrew V Kossenkov; For Yue Tso; Jayamanna Wickramasinghe; Sara R Privatt; Owen Ngalamika; John R Ngowi; Julius Mwaiselage; Paul M Lieberman; John T West; Charles Wood
Journal:  PLoS Pathog       Date:  2020-07-24       Impact factor: 6.823

8.  Expression of CD40L on CD4+T cells distinguishes active versus inactive HIV-associated Kaposi's Sarcoma.

Authors:  Owen Ngalamika; Musonda Kawimbe; Marie Claire Mukasine
Journal:  Cancer Treat Res Commun       Date:  2021-03-23

9.  Viral and immunological markers of HIV-associated Kaposi sarcoma recurrence.

Authors:  Owen Ngalamika; Marie Claire Mukasine; Musonda Kawimbe; Faheema Vally
Journal:  PLoS One       Date:  2021-07-02       Impact factor: 3.240

10.  Kaposi's sarcoma-associated herpesvirus protein ORF75 among HIV-1 patients in Kenya.

Authors:  Rodgers N Demba; Sylviah M Aradi; Matilu Mwau; Walter O Mwanda
Journal:  Afr J Lab Med       Date:  2020-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.